Milenko Cicmil
Venture Partner at Cure Ventures
About
A drug discovery and development professional with over 20 years of experience leading multidisciplinary teams and business development. Holds deep expertise in inflammation, autoimmunity, and oncology, with background spanning multiple modalities including small molecules, biologics, and peptides. Co-founder and CEO of portfolio company Tasca Therapeutics.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures